Affiliation:
1. Division of Nephrology, Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA
Abstract
Adipose tissue is a complex organ whose functions go beyond being an energy reservoir to sustain proper body energy homeostasis. Functioning as an endocrine organ, the adipose tissue has an active role in the body’s metabolic balance regulation through several secreted factors generally termed as adipokines. Thus, adipose tissue dysregulation in chronic kidney disease (CKD) can have a deep impact in the pathophysiology of diseases associated with metabolic dysregulation including metabolic syndrome, insulin resistance (IR), atherosclerosis, and even cachexia. CKD is a progressive disorder linked to increased morbidity and mortality. Despite being characterized by renal function loss, CKD is accompanied by metabolic disturbances such as dyslipidemia, protein energy wasting, chronic low-grade inflammation, IR, and lipid redistribution. Thus far, the mechanisms by which these changes occur and the role of adipose tissue in CKD development and progression are unclear. Further understanding of how these factors develop could have implications for the management of CKD by helping identify pharmacological targets to improve CKD outcomes.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference140 articles.
1. Update on the burden of CKD.;Coresh;J Am Soc Nephrol,2017
2. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome—the heart of the matter.;Pecoits-Filho;Nephrol Dial Transplant,2002
3. Inflammation in end-stage renal disease: sources, consequences, and therapy.;Stenvinkel;Semin Dial,2002
4. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.;Go;N Engl J Med,2004
5. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.;Silverstein;Pediatr Nephrol,2009